speb/financial-data huggingface dataset:
DRREDDY.NS balance_sheet (annual, 2023-03-31) — Goodwill And Other Intangible Assets: 35094000000.00
DRREDDY.NS balance_sheet (annual, 2023-03-31) — Gross Accounts Receivable: 73743000000.00
DRREDDY.NS balance_sheet (annual, 2023-03-31) — Gross PPE: 152269000000.00
DRREDDY.NS income_statement (annual, 2023-03-31) — Gross Profit: 139343000000.00
DRREDDY.NS balance_sheet (annual, 2023-03-31) — Hedging Assets Current: 1232000000.00
DRREDDY.NS income_statement (annual, 2023-03-31) — Impairment Of Capital Assets: 699000000.00
DRREDDY.NS income_statement (annual, 2023-03-31) — Interest Expense: 1428000000.00
DRREDDY.NS income_statement (annual, 2023-03-31) — Interest Expense Non Operating: 1428000000.00
DRREDDY.NS income_statement (annual, 2023-03-31) — Interest Income: 1180000000.00
DRREDDY.NS income_statement (annual, 2023-03-31) — Interest Income Non Operating: 1180000000.00
DRREDDY.NS cash_flow (annual, 2023-03-31) — Interest Paid Cff: -1853000000.00
DRREDDY.NS cash_flow (annual, 2023-03-31) — Interest Received Cfi: 777000000.00
DRREDDY.NS balance_sheet (annual, 2023-03-31) — Inventory: 48670000000.00
DRREDDY.NS balance_sheet (annual, 2023-03-31) — Invested Capital: 242181000000.00
DRREDDY.NS cash_flow (annual, 2023-03-31) — Investing Cash Flow: -41373000000.00
DRREDDY.NS balance_sheet (annual, 2023-03-31) — Investmentin Financial Assets: 660000000.00
DRREDDY.NS balance_sheet (annual, 2023-03-31) — Investments And Advances: 5362000000.00
DRREDDY.NS cash_flow (annual, 2023-03-31) — Issuance Of Capital Stock: 368000000.00
DRREDDY.NS cash_flow (annual, 2023-03-31) — Issuance Of Debt: 0.00
DRREDDY.NS balance_sheet (annual, 2023-03-31) — Land And Improvements: 4318000000.00
DRREDDY.NS balance_sheet (annual, 2023-03-31) — Line Of Credit: 7390000000.00
DRREDDY.NS balance_sheet (annual, 2023-03-31) — Long Term Capital Lease Obligation: 1278000000.00
DRREDDY.NS balance_sheet (annual, 2023-03-31) — Long Term Debt And Capital Lease Obligation: 1278000000.00
DRREDDY.NS cash_flow (annual, 2023-03-31) — Long Term Debt Issuance: 0.00
DRREDDY.NS cash_flow (annual, 2023-03-31) — Long Term Debt Payments: -1015000000.00
DRREDDY.NS balance_sheet (annual, 2023-03-31) — Long Term Equity Investment: 4702000000.00
DRREDDY.NS balance_sheet (annual, 2023-03-31) — Long Term Provisions: 59000000.00
DRREDDY.NS balance_sheet (annual, 2023-03-31) — Machinery Furniture Equipment: 108268000000.00
DRREDDY.NS income_statement (annual, 2023-03-31) — Minority Interests: 0.00
DRREDDY.NS cash_flow (annual, 2023-03-31) — Net Business Purchase And Sale: 0.00
DRREDDY.NS cash_flow (annual, 2023-03-31) — Net Common Stock Issuance: 368000000.00
DRREDDY.NS balance_sheet (annual, 2023-03-31) — Net Debt: 5411000000.00
DRREDDY.NS cash_flow (annual, 2023-03-31) — Net Foreign Currency Exchange Gain Loss: -939000000.00
DRREDDY.NS income_statement (annual, 2023-03-31) — Net Income: 45067000000.00
DRREDDY.NS income_statement (annual, 2023-03-31) — Net Income Common Stockholders: 45067000000.00
DRREDDY.NS income_statement (annual, 2023-03-31) — Net Income Continuous Operations: 45067000000.00
DRREDDY.NS income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: 45067000000.00
DRREDDY.NS income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: 45067000000.00
DRREDDY.NS cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: 45067000000.00
DRREDDY.NS income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: 45067000000.00
DRREDDY.NS cash_flow (annual, 2023-03-31) — Net Intangibles Purchase And Sale: -7543000000.00
DRREDDY.NS income_statement (annual, 2023-03-31) — Net Interest Income: -248000000.00
DRREDDY.NS cash_flow (annual, 2023-03-31) — Net Investment Purchase And Sale: -23366000000.00
DRREDDY.NS cash_flow (annual, 2023-03-31) — Net Issuance Payments Of Debt: -20397000000.00
DRREDDY.NS cash_flow (annual, 2023-03-31) — Net Long Term Debt Issuance: -1015000000.00
DRREDDY.NS income_statement (annual, 2023-03-31) — Net Non Operating Interest Income Expense: -248000000.00
DRREDDY.NS balance_sheet (annual, 2023-03-31) — Net PPE: 66462000000.00
DRREDDY.NS cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: -11241000000.00
DRREDDY.NS cash_flow (annual, 2023-03-31) — Net Short Term Debt Issuance: -19382000000.00
DRREDDY.NS balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 195897000000.00
DRREDDY.NS balance_sheet (annual, 2023-03-31) — Non Current Accounts Receivable: 2687000000.00
DRREDDY.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Assets: 7196000000.00
DRREDDY.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Liabilities: 2388000000.00
DRREDDY.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Revenue: 1555000000.00
DRREDDY.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Assets: 7196000000.00
DRREDDY.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Liabilities: 833000000.00
DRREDDY.NS balance_sheet (annual, 2023-03-31) — Non Current Prepaid Assets: 668000000.00
DRREDDY.NS income_statement (annual, 2023-03-31) — Normalized EBITDA: 73240000000.00
DRREDDY.NS income_statement (annual, 2023-03-31) — Normalized Income: 44173750000.00
DRREDDY.NS cash_flow (annual, 2023-03-31) — Operating Cash Flow: 58875000000.00
DRREDDY.NS cash_flow (annual, 2023-03-31) — Operating Gains Losses: -1101000000.00
DRREDDY.NS income_statement (annual, 2023-03-31) — Operating Income: 59054000000.00
DRREDDY.NS income_statement (annual, 2023-03-31) — Operating Revenue: 245879000000.00
DRREDDY.NS balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 830783660.00
DRREDDY.NS balance_sheet (annual, 2023-03-31) — Other Current Assets: 5175000000.00
DRREDDY.NS balance_sheet (annual, 2023-03-31) — Other Current Borrowings: 3800000000.00
DRREDDY.NS balance_sheet (annual, 2023-03-31) — Other Current Liabilities: 3739000000.00
DRREDDY.NS balance_sheet (annual, 2023-03-31) — Other Equity Adjustments: 886000000.00
DRREDDY.NS balance_sheet (annual, 2023-03-31) — Other Equity Interest: 4707000000.00
DRREDDY.NS income_statement (annual, 2023-03-31) — Other Income Expense: 1561000000.00
DRREDDY.NS balance_sheet (annual, 2023-03-31) — Other Intangible Assets: 30849000000.00
DRREDDY.NS cash_flow (annual, 2023-03-31) — Other Non Cash Items: 248000000.00
DRREDDY.NS balance_sheet (annual, 2023-03-31) — Other Non Current Assets: 132000000.00
DRREDDY.NS balance_sheet (annual, 2023-03-31) — Other Non Current Liabilities: 1293000000.00
DRREDDY.NS income_statement (annual, 2023-03-31) — Other Operating Expenses: -7118000000.00
DRREDDY.NS balance_sheet (annual, 2023-03-31) — Other Payable: 20632000000.00
DRREDDY.NS balance_sheet (annual, 2023-03-31) — Other Properties: 3000000.00
DRREDDY.NS balance_sheet (annual, 2023-03-31) — Other Receivables: 10718000000.00
DRREDDY.NS balance_sheet (annual, 2023-03-31) — Other Short Term Investments: 56018000000.00
DRREDDY.NS balance_sheet (annual, 2023-03-31) — Payables: 40633000000.00
DRREDDY.NS balance_sheet (annual, 2023-03-31) — Payables And Accrued Expenses: 62477000000.00
DRREDDY.NS balance_sheet (annual, 2023-03-31) — Prepaid Assets: 4176000000.00
DRREDDY.NS income_statement (annual, 2023-03-31) — Pretax Income: 60367000000.00
DRREDDY.NS balance_sheet (annual, 2023-03-31) — Properties: 0.00
DRREDDY.NS cash_flow (annual, 2023-03-31) — Provisionand Write Offof Assets: 205000000.00
DRREDDY.NS cash_flow (annual, 2023-03-31) — Purchase Of Business: 0.00
DRREDDY.NS cash_flow (annual, 2023-03-31) — Purchase Of Intangibles: -7543000000.00
DRREDDY.NS cash_flow (annual, 2023-03-31) — Purchase Of Investment: -136171000000.00
DRREDDY.NS cash_flow (annual, 2023-03-31) — Purchase Of PPE: -11323000000.00
DRREDDY.NS balance_sheet (annual, 2023-03-31) — Raw Materials: 16001000000.00
DRREDDY.NS balance_sheet (annual, 2023-03-31) — Receivables: 83203000000.00
DRREDDY.NS income_statement (annual, 2023-03-31) — Reconciled Cost Of Revenue: 106536000000.00
DRREDDY.NS income_statement (annual, 2023-03-31) — Reconciled Depreciation: 12636000000.00
DRREDDY.NS cash_flow (annual, 2023-03-31) — Repayment Of Debt: -1015000000.00
DRREDDY.NS cash_flow (annual, 2023-03-31) — Repurchase Of Capital Stock: 0.00
DRREDDY.NS income_statement (annual, 2023-03-31) — Research And Development: 19381000000.00
DRREDDY.NS balance_sheet (annual, 2023-03-31) — Retained Earnings: 215593000000.00
DRREDDY.NS cash_flow (annual, 2023-03-31) — Sale Of Intangibles: 0.00
DRREDDY.NS cash_flow (annual, 2023-03-31) — Sale Of Investment: 112805000000.00
DRREDDY.NS cash_flow (annual, 2023-03-31) — Sale Of PPE: 82000000.00
DRREDDY.NS income_statement (annual, 2023-03-31) — Selling General And Administration: 68026000000.00
DRREDDY.NS balance_sheet (annual, 2023-03-31) — Share Issued: 832639380.00
DRREDDY.NS cash_flow (annual, 2023-03-31) — Short Term Debt Payments: -19382000000.00
DRREDDY.NS income_statement (annual, 2023-03-31) — Special Income Charges: -1910000000.00
DRREDDY.NS cash_flow (annual, 2023-03-31) — Stock Based Compensation: 397000000.00
DRREDDY.NS balance_sheet (annual, 2023-03-31) — Stockholders Equity: 230991000000.00
DRREDDY.NS balance_sheet (annual, 2023-03-31) — Tangible Book Value: 195897000000.00
DRREDDY.NS income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: 297750000.00
DRREDDY.NS income_statement (annual, 2023-03-31) — Tax Provision: 15300000000.00
DRREDDY.NS income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.25
DRREDDY.NS balance_sheet (annual, 2023-03-31) — Taxes Receivable: 2687000000.00
DRREDDY.NS cash_flow (annual, 2023-03-31) — Taxes Refund Paid: -10714000000.00
DRREDDY.NS balance_sheet (annual, 2023-03-31) — Total Assets: 321854000000.00
DRREDDY.NS balance_sheet (annual, 2023-03-31) — Total Capitalization: 230991000000.00
DRREDDY.NS balance_sheet (annual, 2023-03-31) — Total Debt: 13472000000.00
DRREDDY.NS balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: 230991000000.00
DRREDDY.NS income_statement (annual, 2023-03-31) — Total Expenses: 186825000000.00
DRREDDY.NS balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 90863000000.00
DRREDDY.NS balance_sheet (annual, 2023-03-31) — Total Non Current Assets: 117601000000.00
DRREDDY.NS balance_sheet (annual, 2023-03-31) — Total Non Current Liabilities Net Minority Interest: 5018000000.00
DRREDDY.NS income_statement (annual, 2023-03-31) — Total Operating Income As Reported: 57144000000.00
DRREDDY.NS balance_sheet (annual, 2023-03-31) — Total Tax Payable: 2144000000.00
DRREDDY.NS income_statement (annual, 2023-03-31) — Total Unusual Items: 1191000000.00
DRREDDY.NS income_statement (annual, 2023-03-31) — Total Unusual Items Excluding Goodwill: 1191000000.00
DRREDDY.NS balance_sheet (annual, 2023-03-31) — Treasury Shares Number: 1855720.00
DRREDDY.NS balance_sheet (annual, 2023-03-31) — Treasury Stock: 1269000000.00
DRREDDY.NS cash_flow (annual, 2023-03-31) — Unrealized Gain Loss On Investment Securities: -876000000.00
DRREDDY.NS balance_sheet (annual, 2023-03-31) — Work In Process: 11698000000.00
DRREDDY.NS balance_sheet (annual, 2023-03-31) — Working Capital: 118408000000.00
DRREDDY.NS income_statement (annual, 2023-03-31) — Write Off: 699000000.00
DRREDDY.NS income_statement (annual, 2024-03-31) — +Operating Expense: 98299000000.00
DRREDDY.NS income_statement (annual, 2024-03-31) — +Total Revenue: 279164000000.00
DRREDDY.NS balance_sheet (annual, 2024-03-31) — Accounts Payable: 21547000000.00
DRREDDY.NS balance_sheet (annual, 2024-03-31) — Accounts Receivable: 80298000000.00
DRREDDY.NS balance_sheet (annual, 2024-03-31) — Accumulated Depreciation: -93254000000.00
DRREDDY.NS balance_sheet (annual, 2024-03-31) — Additional Paid In Capital: 10938000000.00
DRREDDY.NS balance_sheet (annual, 2024-03-31) — Allowance For Doubtful Accounts Receivable: -1451000000.00
DRREDDY.NS cash_flow (annual, 2024-03-31) — Amortization Cash Flow: 5265000000.00
DRREDDY.NS cash_flow (annual, 2024-03-31) — Amortization Of Intangibles: 5265000000.00
DRREDDY.NS cash_flow (annual, 2024-03-31) — Asset Impairment Charge: 3566000000.00
DRREDDY.NS balance_sheet (annual, 2024-03-31) — Available For Sale Securities: 249000000.00
DRREDDY.NS income_statement (annual, 2024-03-31) — Basic Average Shares: 831976016.00
DRREDDY.NS income_statement (annual, 2024-03-31) — Basic EPS: 67.04
DRREDDY.NS cash_flow (annual, 2024-03-31) — Beginning Cash Position: 5779000000.00
DRREDDY.NS balance_sheet (annual, 2024-03-31) — Buildings And Improvements: 33032000000.00
DRREDDY.NS cash_flow (annual, 2024-03-31) — Capital Expenditure: -27435000000.00
DRREDDY.NS balance_sheet (annual, 2024-03-31) — Capital Lease Obligations: 3497000000.00
DRREDDY.NS balance_sheet (annual, 2024-03-31) — Capital Stock: 834000000.00
DRREDDY.NS balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 7107000000.00
DRREDDY.NS balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Short Term Investments: 81470000000.00
DRREDDY.NS cash_flow (annual, 2024-03-31) — Cash Dividends Paid: -6648000000.00
DRREDDY.NS balance_sheet (annual, 2024-03-31) — Cash Equivalents: 2585000000.00
DRREDDY.NS balance_sheet (annual, 2024-03-31) — Cash Financial: 4522000000.00
DRREDDY.NS cash_flow (annual, 2024-03-31) — Cash Flow From Continuing Financing Activities: -3763000000.00
DRREDDY.NS cash_flow (annual, 2024-03-31) — Cash Flow From Continuing Investing Activities: -40283000000.00
DRREDDY.NS cash_flow (annual, 2024-03-31) — Cash Flow From Continuing Operating Activities: 45433000000.00
DRREDDY.NS cash_flow (annual, 2024-03-31) — Change In Inventory: -18445000000.00
DRREDDY.NS cash_flow (annual, 2024-03-31) — Change In Other Working Capital: 2857000000.00
DRREDDY.NS cash_flow (annual, 2024-03-31) — Change In Payable: 3460000000.00
DRREDDY.NS cash_flow (annual, 2024-03-31) — Change In Payables And Accrued Expense: 3460000000.00
DRREDDY.NS cash_flow (annual, 2024-03-31) — Change In Receivables: -8054000000.00
DRREDDY.NS cash_flow (annual, 2024-03-31) — Change In Working Capital: -20182000000.00
DRREDDY.NS cash_flow (annual, 2024-03-31) — Changes In Cash: 1387000000.00
DRREDDY.NS balance_sheet (annual, 2024-03-31) — Common Stock: 834000000.00
DRREDDY.NS balance_sheet (annual, 2024-03-31) — Common Stock Equity: 280550000000.00
DRREDDY.NS cash_flow (annual, 2024-03-31) — Common Stock Issuance: 805000000.00
DRREDDY.NS cash_flow (annual, 2024-03-31) — Common Stock Payments: 0.00
DRREDDY.NS balance_sheet (annual, 2024-03-31) — Construction In Progress: 14460000000.00
DRREDDY.NS income_statement (annual, 2024-03-31) — Cost Of Revenue: 115557000000.00
DRREDDY.NS balance_sheet (annual, 2024-03-31) — Current Accrued Expenses: 24783000000.00
DRREDDY.NS balance_sheet (annual, 2024-03-31) — Current Assets: 248049000000.00
DRREDDY.NS balance_sheet (annual, 2024-03-31) — Current Capital Lease Obligation: 1307000000.00
DRREDDY.NS balance_sheet (annual, 2024-03-31) — Current Debt: 12723000000.00
DRREDDY.NS balance_sheet (annual, 2024-03-31) — Current Debt And Capital Lease Obligation: 14030000000.00
DRREDDY.NS balance_sheet (annual, 2024-03-31) — Current Deferred Liabilities: 1435000000.00
DRREDDY.NS balance_sheet (annual, 2024-03-31) — Current Deferred Revenue: 1435000000.00
DRREDDY.NS balance_sheet (annual, 2024-03-31) — Current Liabilities: 96039000000.00
DRREDDY.NS balance_sheet (annual, 2024-03-31) — Current Provisions: 5383000000.00
DRREDDY.NS cash_flow (annual, 2024-03-31) — Deferred Income Tax: 16186000000.00
DRREDDY.NS cash_flow (annual, 2024-03-31) — Deferred Tax: 16186000000.00
DRREDDY.NS cash_flow (annual, 2024-03-31) — Depreciation: 9576000000.00
DRREDDY.NS cash_flow (annual, 2024-03-31) — Depreciation Amortization Depletion: 14841000000.00
DRREDDY.NS cash_flow (annual, 2024-03-31) — Depreciation And Amortization: 14841000000.00
DRREDDY.NS income_statement (annual, 2024-03-31) — Diluted Average Shares: 833542545.00
DRREDDY.NS income_statement (annual, 2024-03-31) — Diluted EPS: 66.92
DRREDDY.NS income_statement (annual, 2024-03-31) — Diluted NI Availto Com Stockholders: 55684000000.00
DRREDDY.NS cash_flow (annual, 2024-03-31) — Dividends Received Cfi: 445000000.00
DRREDDY.NS income_statement (annual, 2024-03-31) — EBIT: 73581000000.00
DRREDDY.NS income_statement (annual, 2024-03-31) — EBITDA: 88422000000.00
DRREDDY.NS income_statement (annual, 2024-03-31) — Earnings From Equity Interest: 147000000.00
DRREDDY.NS cash_flow (annual, 2024-03-31) — Earnings Losses From Equity Investments: -147000000.00
DRREDDY.NS cash_flow (annual, 2024-03-31) — Effect Of Exchange Rate Changes: -59000000.00
DRREDDY.NS cash_flow (annual, 2024-03-31) — End Cash Position: 7107000000.00
DRREDDY.NS balance_sheet (annual, 2024-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 810000000.00
DRREDDY.NS cash_flow (annual, 2024-03-31) — Financing Cash Flow: -3763000000.00
DRREDDY.NS balance_sheet (annual, 2024-03-31) — Finished Goods: 25249000000.00
DRREDDY.NS cash_flow (annual, 2024-03-31) — Free Cash Flow: 17998000000.00
DRREDDY.NS income_statement (annual, 2024-03-31) — Gain On Sale Of Ppe: 900000000.00
DRREDDY.NS income_statement (annual, 2024-03-31) — Gain On Sale Of Security: 3427000000.00
DRREDDY.NS balance_sheet (annual, 2024-03-31) — Gains Losses Not Affecting Retained Earnings: 653000000.00
DRREDDY.NS balance_sheet (annual, 2024-03-31) — Goodwill: 4253000000.00
DRREDDY.NS balance_sheet (annual, 2024-03-31) — Goodwill And Other Intangible Assets: 41204000000.00
DRREDDY.NS balance_sheet (annual, 2024-03-31) — Gross Accounts Receivable: 81749000000.00
DRREDDY.NS balance_sheet (annual, 2024-03-31) — Gross PPE: 170140000000.00
DRREDDY.NS income_statement (annual, 2024-03-31) — Gross Profit: 163607000000.00
DRREDDY.NS balance_sheet (annual, 2024-03-31) — Hedging Assets Current: 169000000.00
DRREDDY.NS income_statement (annual, 2024-03-31) — Impairment Of Capital Assets: 3000000.00
DRREDDY.NS income_statement (annual, 2024-03-31) — Interest Expense: 1711000000.00
DRREDDY.NS income_statement (annual, 2024-03-31) — Interest Expense Non Operating: 1711000000.00
DRREDDY.NS income_statement (annual, 2024-03-31) — Interest Income: 2278000000.00
DRREDDY.NS income_statement (annual, 2024-03-31) — Interest Income Non Operating: 2278000000.00
DRREDDY.NS cash_flow (annual, 2024-03-31) — Interest Paid Cff: -2266000000.00
DRREDDY.NS cash_flow (annual, 2024-03-31) — Interest Received Cfi: 1338000000.00
DRREDDY.NS balance_sheet (annual, 2024-03-31) — Inventory: 63552000000.00
DRREDDY.NS balance_sheet (annual, 2024-03-31) — Invested Capital: 297073000000.00
DRREDDY.NS cash_flow (annual, 2024-03-31) — Investing Cash Flow: -40283000000.00
DRREDDY.NS balance_sheet (annual, 2024-03-31) — Investmentin Financial Assets: 1059000000.00
DRREDDY.NS balance_sheet (annual, 2024-03-31) — Investments And Advances: 5255000000.00
DRREDDY.NS cash_flow (annual, 2024-03-31) — Issuance Of Capital Stock: 805000000.00
DRREDDY.NS cash_flow (annual, 2024-03-31) — Issuance Of Debt: 3800000000.00
DRREDDY.NS balance_sheet (annual, 2024-03-31) — Land And Improvements: 4309000000.00
DRREDDY.NS balance_sheet (annual, 2024-03-31) — Line Of Credit: 12723000000.00
DRREDDY.NS balance_sheet (annual, 2024-03-31) — Long Term Capital Lease Obligation: 2190000000.00
DRREDDY.NS balance_sheet (annual, 2024-03-31) — Long Term Debt: 3800000000.00
DRREDDY.NS balance_sheet (annual, 2024-03-31) — Long Term Debt And Capital Lease Obligation: 5990000000.00
DRREDDY.NS cash_flow (annual, 2024-03-31) — Long Term Debt Issuance: 3800000000.00
DRREDDY.NS cash_flow (annual, 2024-03-31) — Long Term Debt Payments: -4947000000.00
DRREDDY.NS balance_sheet (annual, 2024-03-31) — Long Term Equity Investment: 4196000000.00
DRREDDY.NS balance_sheet (annual, 2024-03-31) — Long Term Provisions: 61000000.00
DRREDDY.NS balance_sheet (annual, 2024-03-31) — Machinery Furniture Equipment: 118338000000.00
DRREDDY.NS balance_sheet (annual, 2024-03-31) — Minority Interest: 0.00
DRREDDY.NS income_statement (annual, 2024-03-31) — Minority Interests: 0.00
DRREDDY.NS cash_flow (annual, 2024-03-31) — Net Business Purchase And Sale: -12000000.00
DRREDDY.NS cash_flow (annual, 2024-03-31) — Net Common Stock Issuance: 805000000.00
DRREDDY.NS balance_sheet (annual, 2024-03-31) — Net Debt: 9416000000.00
DRREDDY.NS cash_flow (annual, 2024-03-31) — Net Foreign Currency Exchange Gain Loss: -534000000.00
DRREDDY.NS income_statement (annual, 2024-03-31) — Net Income: 55684000000.00
DRREDDY.NS income_statement (annual, 2024-03-31) — Net Income Common Stockholders: 55684000000.00
DRREDDY.NS income_statement (annual, 2024-03-31) — Net Income Continuous Operations: 55684000000.00
DRREDDY.NS income_statement (annual, 2024-03-31) — Net Income From Continuing And Discontinued Operation: 55684000000.00
DRREDDY.NS income_statement (annual, 2024-03-31) — Net Income From Continuing Operation Net Minority Interest: 55684000000.00
DRREDDY.NS cash_flow (annual, 2024-03-31) — Net Income From Continuing Operations: 55684000000.00
DRREDDY.NS income_statement (annual, 2024-03-31) — Net Income Including Noncontrolling Interests: 55684000000.00
DRREDDY.NS cash_flow (annual, 2024-03-31) — Net Intangibles Purchase And Sale: -11011000000.00
DRREDDY.NS income_statement (annual, 2024-03-31) — Net Interest Income: 567000000.00
DRREDDY.NS cash_flow (annual, 2024-03-31) — Net Investment Purchase And Sale: -15704000000.00
DRREDDY.NS cash_flow (annual, 2024-03-31) — Net Issuance Payments Of Debt: 4346000000.00
DRREDDY.NS cash_flow (annual, 2024-03-31) — Net Long Term Debt Issuance: -1147000000.00
DRREDDY.NS income_statement (annual, 2024-03-31) — Net Non Operating Interest Income Expense: 567000000.00
DRREDDY.NS balance_sheet (annual, 2024-03-31) — Net PPE: 76886000000.00
DRREDDY.NS cash_flow (annual, 2024-03-31) — Net PPE Purchase And Sale: -15339000000.00
DRREDDY.NS cash_flow (annual, 2024-03-31) — Net Short Term Debt Issuance: 5493000000.00
DRREDDY.NS balance_sheet (annual, 2024-03-31) — Net Tangible Assets: 239346000000.00
DRREDDY.NS balance_sheet (annual, 2024-03-31) — Non Current Accounts Receivable: 3718000000.00
DRREDDY.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Assets: 10774000000.00
DRREDDY.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Liabilities: 2102000000.00
DRREDDY.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Revenue: 1193000000.00
DRREDDY.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Assets: 10774000000.00
DRREDDY.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Liabilities: 909000000.00
DRREDDY.NS balance_sheet (annual, 2024-03-31) — Non Current Prepaid Assets: 747000000.00
DRREDDY.NS income_statement (annual, 2024-03-31) — Normalized EBITDA: 82574000000.00
DRREDDY.NS income_statement (annual, 2024-03-31) — Normalized Income: 51181040000.00
DRREDDY.NS cash_flow (annual, 2024-03-31) — Operating Cash Flow: 45433000000.00
DRREDDY.NS cash_flow (annual, 2024-03-31) — Operating Gains Losses: -1581000000.00
DRREDDY.NS income_statement (annual, 2024-03-31) — Operating Income: 65308000000.00
DRREDDY.NS income_statement (annual, 2024-03-31) — Operating Revenue: 279164000000.00
DRREDDY.NS balance_sheet (annual, 2024-03-31) — Ordinary Shares Number: 832642375.00
DRREDDY.NS balance_sheet (annual, 2024-03-31) — Other Current Assets: 2771000000.00
DRREDDY.NS balance_sheet (annual, 2024-03-31) — Other Current Borrowings: 10223000000.00
DRREDDY.NS balance_sheet (annual, 2024-03-31) — Other Current Liabilities: 6034000000.00
DRREDDY.NS balance_sheet (annual, 2024-03-31) — Other Equity Adjustments: 653000000.00
DRREDDY.NS balance_sheet (annual, 2024-03-31) — Other Equity Interest: 3859000000.00
DRREDDY.NS income_statement (annual, 2024-03-31) — Other Income Expense: 5995000000.00
DRREDDY.NS balance_sheet (annual, 2024-03-31) — Other Intangible Assets: 36951000000.00
DRREDDY.NS cash_flow (annual, 2024-03-31) — Other Non Cash Items: -567000000.00
DRREDDY.NS balance_sheet (annual, 2024-03-31) — Other Non Current Assets: 885000000.00
DRREDDY.NS balance_sheet (annual, 2024-03-31) — Other Non Current Liabilities: 2776000000.00
DRREDDY.NS income_statement (annual, 2024-03-31) — Other Operating Expenses: -1775000000.00
DRREDDY.NS balance_sheet (annual, 2024-03-31) — Other Payable: 20485000000.00
DRREDDY.NS balance_sheet (annual, 2024-03-31) — Other Properties: 3000000.00
DRREDDY.NS balance_sheet (annual, 2024-03-31) — Other Receivables: 15040000000.00
DRREDDY.NS balance_sheet (annual, 2024-03-31) — Other Short Term Investments: 74363000000.00
DRREDDY.NS income_statement (annual, 2024-03-31) — Other Special Charges: -1524000000.00
DRREDDY.NS balance_sheet (annual, 2024-03-31) — Payables: 44374000000.00
DRREDDY.NS balance_sheet (annual, 2024-03-31) — Payables And Accrued Expenses: 69157000000.00
DRREDDY.NS balance_sheet (annual, 2024-03-31) — Prepaid Assets: 4749000000.00
DRREDDY.NS income_statement (annual, 2024-03-31) — Pretax Income: 71870000000.00
DRREDDY.NS balance_sheet (annual, 2024-03-31) — Properties: 0.00
DRREDDY.NS cash_flow (annual, 2024-03-31) — Provisionand Write Offof Assets: 275000000.00
DRREDDY.NS cash_flow (annual, 2024-03-31) — Purchase Of Business: -12000000.00
DRREDDY.NS cash_flow (annual, 2024-03-31) — Purchase Of Intangibles: -11032000000.00
DRREDDY.NS cash_flow (annual, 2024-03-31) — Purchase Of Investment: -41648000000.00
DRREDDY.NS cash_flow (annual, 2024-03-31) — Purchase Of PPE: -16403000000.00
DRREDDY.NS balance_sheet (annual, 2024-03-31) — Raw Materials: 24081000000.00
DRREDDY.NS balance_sheet (annual, 2024-03-31) — Receivables: 95338000000.00
DRREDDY.NS income_statement (annual, 2024-03-31) — Reconciled Cost Of Revenue: 115557000000.00
DRREDDY.NS income_statement (annual, 2024-03-31) — Reconciled Depreciation: 14841000000.00
DRREDDY.NS cash_flow (annual, 2024-03-31) — Repayment Of Debt: -4947000000.00
DRREDDY.NS cash_flow (annual, 2024-03-31) — Repurchase Of Capital Stock: 0.00
DRREDDY.NS income_statement (annual, 2024-03-31) — Research And Development: 22873000000.00
DRREDDY.NS balance_sheet (annual, 2024-03-31) — Retained Earnings: 265257000000.00
DRREDDY.NS cash_flow (annual, 2024-03-31) — Sale Of Intangibles: 21000000.00
DRREDDY.NS cash_flow (annual, 2024-03-31) — Sale Of Investment: 25944000000.00
DRREDDY.NS cash_flow (annual, 2024-03-31) — Sale Of PPE: 1064000000.00
DRREDDY.NS income_statement (annual, 2024-03-31) — Selling General And Administration: 77201000000.00
DRREDDY.NS balance_sheet (annual, 2024-03-31) — Share Issued: 834091330.00
DRREDDY.NS income_statement (annual, 2024-03-31) — Special Income Charges: 2421000000.00
DRREDDY.NS cash_flow (annual, 2024-03-31) — Stock Based Compensation: 407000000.00
DRREDDY.NS balance_sheet (annual, 2024-03-31) — Stockholders Equity: 280550000000.00
DRREDDY.NS balance_sheet (annual, 2024-03-31) — Tangible Book Value: 239346000000.00
DRREDDY.NS income_statement (annual, 2024-03-31) — Tax Effect Of Unusual Items: 1345040000.00
DRREDDY.NS income_statement (annual, 2024-03-31) — Tax Provision: 16186000000.00
DRREDDY.NS income_statement (annual, 2024-03-31) — Tax Rate For Calcs: 0.23
DRREDDY.NS cash_flow (annual, 2024-03-31) — Taxes Refund Paid: -20047000000.00
DRREDDY.NS balance_sheet (annual, 2024-03-31) — Total Assets: 387518000000.00
DRREDDY.NS balance_sheet (annual, 2024-03-31) — Total Capitalization: 284350000000.00
DRREDDY.NS balance_sheet (annual, 2024-03-31) — Total Debt: 20020000000.00
DRREDDY.NS balance_sheet (annual, 2024-03-31) — Total Equity Gross Minority Interest: 280550000000.00
DRREDDY.NS income_statement (annual, 2024-03-31) — Total Expenses: 213856000000.00
DRREDDY.NS balance_sheet (annual, 2024-03-31) — Total Liabilities Net Minority Interest: 106968000000.00
DRREDDY.NS balance_sheet (annual, 2024-03-31) — Total Non Current Assets: 139469000000.00
DRREDDY.NS balance_sheet (annual, 2024-03-31) — Total Non Current Liabilities Net Minority Interest: 10929000000.00
DRREDDY.NS income_statement (annual, 2024-03-31) — Total Operating Income As Reported: 67729000000.00
DRREDDY.NS balance_sheet (annual, 2024-03-31) — Total Tax Payable: 2342000000.00
DRREDDY.NS income_statement (annual, 2024-03-31) — Total Unusual Items: 5848000000.00
DRREDDY.NS income_statement (annual, 2024-03-31) — Total Unusual Items Excluding Goodwill: 5848000000.00
DRREDDY.NS balance_sheet (annual, 2024-03-31) — Treasury Shares Number: 1448955.00
DRREDDY.NS balance_sheet (annual, 2024-03-31) — Treasury Stock: 991000000.00
DRREDDY.NS cash_flow (annual, 2024-03-31) — Unrealized Gain Loss On Investment Securities: -3149000000.00
DRREDDY.NS balance_sheet (annual, 2024-03-31) — Work In Process: 14222000000.00
DRREDDY.NS balance_sheet (annual, 2024-03-31) — Working Capital: 152010000000.00
DRREDDY.NS income_statement (annual, 2024-03-31) — Write Off: 3000000.00
DRREDDY.NS income_statement (quarterly, 2024-09-30) — Diluted Average Shares: 834086379.00
DRREDDY.NS cash_flow (quarterly, 2024-09-30) — Issuance Of Debt: 0.00
DRREDDY.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt: 3800000000.00
DRREDDY.NS cash_flow (quarterly, 2024-09-30) — Long Term Debt Issuance: 0.00
DRREDDY.NS balance_sheet (quarterly, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -1342000000.00
DRREDDY.NS cash_flow (quarterly, 2024-12-31) — Amortization Cash Flow: 1986000000.00
DRREDDY.NS cash_flow (quarterly, 2024-12-31) — Amortization Of Intangibles: 1986000000.00
DRREDDY.NS balance_sheet (quarterly, 2024-12-31) — Available For Sale Securities: 3073000000.00
DRREDDY.NS income_statement (quarterly, 2024-12-31) — Basic Average Shares: 833313679.00
DRREDDY.NS income_statement (quarterly, 2024-12-31) — Basic EPS: 16.96
DRREDDY.NS balance_sheet (quarterly, 2024-12-31) — Capital Lease Obligations: 4885000000.00
DRREDDY.NS balance_sheet (quarterly, 2024-12-31) — Cash Equivalents: 1839000000.00
DRREDDY.NS balance_sheet (quarterly, 2024-12-31) — Cash Financial: 10450000000.00
DRREDDY.NS balance_sheet (quarterly, 2024-12-31) — Current Accrued Expenses: 24334000000.00
DRREDDY.NS balance_sheet (quarterly, 2024-12-31) — Current Capital Lease Obligation: 1106000000.00
DRREDDY.NS balance_sheet (quarterly, 2024-12-31) — Current Deferred Liabilities: 1997000000.00
DRREDDY.NS balance_sheet (quarterly, 2024-12-31) — Current Deferred Revenue: 1997000000.00
DRREDDY.NS cash_flow (quarterly, 2024-12-31) — Deferred Income Tax: 4704000000.00
DRREDDY.NS cash_flow (quarterly, 2024-12-31) — Deferred Tax: 4704000000.00
DRREDDY.NS cash_flow (quarterly, 2024-12-31) — Depreciation: 2733000000.00
DRREDDY.NS income_statement (quarterly, 2024-12-31) — Diluted Average Shares: 834297521.00
DRREDDY.NS income_statement (quarterly, 2024-12-31) — Diluted EPS: 16.94
DRREDDY.NS cash_flow (quarterly, 2024-12-31) — Dividends Received Cfi: 0.00
DRREDDY.NS balance_sheet (quarterly, 2024-12-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 1203000000.00
DRREDDY.NS balance_sheet (quarterly, 2024-12-31) — Finished Goods: 29007000000.00
DRREDDY.NS income_statement (quarterly, 2024-12-31) — Gain On Sale Of Ppe: 8000000.00
DRREDDY.NS income_statement (quarterly, 2024-12-31) — Gain On Sale Of Security: 94000000.00
DRREDDY.NS balance_sheet (quarterly, 2024-12-31) — Gross Accounts Receivable: 93554000000.00
DRREDDY.NS income_statement (quarterly, 2024-12-31) — Interest Income: 704000000.00
DRREDDY.NS income_statement (quarterly, 2024-12-31) — Interest Income Non Operating: 704000000.00
DRREDDY.NS balance_sheet (quarterly, 2024-12-31) — Investmentin Financial Assets: 4276000000.00
DRREDDY.NS cash_flow (quarterly, 2024-12-31) — Issuance Of Debt: 0.00
DRREDDY.NS balance_sheet (quarterly, 2024-12-31) — Line Of Credit: 42400000000.00
DRREDDY.NS balance_sheet (quarterly, 2024-12-31) — Long Term Capital Lease Obligation: 3779000000.00
DRREDDY.NS balance_sheet (quarterly, 2024-12-31) — Long Term Debt: 3800000000.00
DRREDDY.NS cash_flow (quarterly, 2024-12-31) — Long Term Debt Issuance: 0.00
DRREDDY.NS balance_sheet (quarterly, 2024-12-31) — Non Current Deferred Revenue: 905000000.00
DRREDDY.NS balance_sheet (quarterly, 2024-12-31) — Non Current Prepaid Assets: 753000000.00
DRREDDY.NS balance_sheet (quarterly, 2024-12-31) — Other Payable: 10848000000.00
DRREDDY.NS balance_sheet (quarterly, 2024-12-31) — Other Receivables: 19282000000.00
DRREDDY.NS balance_sheet (quarterly, 2024-12-31) — Prepaid Assets: 5306000000.00
DRREDDY.NS balance_sheet (quarterly, 2024-12-31) — Raw Materials: 26652000000.00
DRREDDY.NS income_statement (quarterly, 2024-12-31) — Research And Development: 6658000000.00
DRREDDY.NS balance_sheet (quarterly, 2024-12-31) — Restricted Cash: 743000000.00
DRREDDY.NS cash_flow (quarterly, 2024-12-31) — Sale Of Intangibles: 0.00
DRREDDY.NS income_statement (quarterly, 2024-12-31) — Total Operating Income As Reported: 18720000000.00
DRREDDY.NS balance_sheet (quarterly, 2024-12-31) — Work In Process: 15971000000.00
DRREDDY.NS income_statement (annual, 2025-03-31) — +Operating Expense: 118414000000.00
DRREDDY.NS income_statement (quarterly, 2025-03-31) — +Operating Expense: 40360000000.00
DRREDDY.NS income_statement (annual, 2025-03-31) — +Total Revenue: 325535000000.00
DRREDDY.NS income_statement (quarterly, 2025-03-31) — +Total Revenue: 85060000000.00
DRREDDY.NS balance_sheet (annual, 2025-03-31) — Accounts Payable: 20053000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 20053000000.00
DRREDDY.NS balance_sheet (annual, 2025-03-31) — Accounts Receivable: 90420000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 90420000000.00
DRREDDY.NS balance_sheet (annual, 2025-03-31) — Accumulated Depreciation: -92619000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -92619000000.00
DRREDDY.NS balance_sheet (annual, 2025-03-31) — Additional Paid In Capital: 11306000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 11306000000.00
DRREDDY.NS balance_sheet (annual, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -1478000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -1478000000.00
DRREDDY.NS cash_flow (annual, 2025-03-31) — Amortization Cash Flow: 6553000000.00
DRREDDY.NS cash_flow (quarterly, 2025-03-31) — Amortization Cash Flow: 1919000000.00
DRREDDY.NS cash_flow (annual, 2025-03-31) — Amortization Of Intangibles: 6553000000.00
DRREDDY.NS cash_flow (quarterly, 2025-03-31) — Amortization Of Intangibles: 1919000000.00
DRREDDY.NS cash_flow (annual, 2025-03-31) — Asset Impairment Charge: 6913000000.00
DRREDDY.NS cash_flow (quarterly, 2025-03-31) — Asset Impairment Charge: 1676000000.00
DRREDDY.NS balance_sheet (annual, 2025-03-31) — Available For Sale Securities: 9050000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-03-31) — Available For Sale Securities: 9050000000.00
DRREDDY.NS income_statement (annual, 2025-03-31) — Basic Average Shares: 832950406.00
DRREDDY.NS income_statement (quarterly, 2025-03-31) — Basic Average Shares: 833315900.00
DRREDDY.NS income_statement (annual, 2025-03-31) — Basic EPS: 67.88
DRREDDY.NS income_statement (quarterly, 2025-03-31) — Basic EPS: 19.12
DRREDDY.NS cash_flow (annual, 2025-03-31) — Beginning Cash Position: 7107000000.00
DRREDDY.NS cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 13032000000.00
DRREDDY.NS balance_sheet (annual, 2025-03-31) — Buildings And Improvements: 34653000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-03-31) — Buildings And Improvements: 34653000000.00
DRREDDY.NS cash_flow (annual, 2025-03-31) — Capital Expenditure: -34398000000.00
DRREDDY.NS cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -11246000000.00
DRREDDY.NS balance_sheet (annual, 2025-03-31) — Capital Lease Obligations: 4921000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 4921000000.00
DRREDDY.NS balance_sheet (annual, 2025-03-31) — Capital Stock: 834000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-03-31) — Capital Stock: 834000000.00
DRREDDY.NS balance_sheet (annual, 2025-03-31) — Cash And Cash Equivalents: 14654000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 14654000000.00
DRREDDY.NS balance_sheet (annual, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 57908000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 57908000000.00
DRREDDY.NS cash_flow (annual, 2025-03-31) — Cash Dividends Paid: -6662000000.00
DRREDDY.NS cash_flow (quarterly, 2025-03-31) — Cash Dividends Paid: 0.00
DRREDDY.NS balance_sheet (annual, 2025-03-31) — Cash Equivalents: 2511000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-03-31) — Cash Equivalents: 2511000000.00
DRREDDY.NS balance_sheet (annual, 2025-03-31) — Cash Financial: 12143000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-03-31) — Cash Financial: 12143000000.00
DRREDDY.NS cash_flow (annual, 2025-03-31) — Cash Flow From Continuing Financing Activities: 18911000000.00
DRREDDY.NS cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -7370000000.00
DRREDDY.NS cash_flow (annual, 2025-03-31) — Cash Flow From Continuing Investing Activities: -58077000000.00
DRREDDY.NS cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -13300000000.00
DRREDDY.NS cash_flow (annual, 2025-03-31) — Cash Flow From Continuing Operating Activities: 46428000000.00
DRREDDY.NS cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 21996000000.00
DRREDDY.NS cash_flow (annual, 2025-03-31) — Change In Account Payable: 340000000.00
DRREDDY.NS cash_flow (annual, 2025-03-31) — Change In Inventory: -12753000000.00
DRREDDY.NS cash_flow (quarterly, 2025-03-31) — Change In Inventory: -363000000.00
DRREDDY.NS cash_flow (annual, 2025-03-31) — Change In Other Working Capital: -7293000000.00
DRREDDY.NS cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: 1586000000.00
DRREDDY.NS cash_flow (annual, 2025-03-31) — Change In Payable: 340000000.00
DRREDDY.NS cash_flow (quarterly, 2025-03-31) — Change In Payable: -2390000000.00
DRREDDY.NS cash_flow (annual, 2025-03-31) — Change In Payables And Accrued Expense: 340000000.00
DRREDDY.NS cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -2390000000.00
DRREDDY.NS cash_flow (annual, 2025-03-31) — Change In Receivables: -10283000000.00
DRREDDY.NS cash_flow (quarterly, 2025-03-31) — Change In Receivables: 1751000000.00
DRREDDY.NS cash_flow (annual, 2025-03-31) — Change In Working Capital: -29989000000.00
DRREDDY.NS cash_flow (quarterly, 2025-03-31) — Change In Working Capital: 584000000.00
DRREDDY.NS cash_flow (annual, 2025-03-31) — Changes In Account Receivables: -10283000000.00
DRREDDY.NS cash_flow (annual, 2025-03-31) — Changes In Cash: 7262000000.00
DRREDDY.NS cash_flow (quarterly, 2025-03-31) — Changes In Cash: 1326000000.00
DRREDDY.NS balance_sheet (annual, 2025-03-31) — Common Stock: 834000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-03-31) — Common Stock: 834000000.00
DRREDDY.NS balance_sheet (annual, 2025-03-31) — Common Stock Equity: 333388000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 333388000000.00
DRREDDY.NS cash_flow (annual, 2025-03-31) — Common Stock Issuance: 193000000.00
DRREDDY.NS cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: -7045000000.00
DRREDDY.NS cash_flow (annual, 2025-03-31) — Common Stock Payments: -1389000000.00
DRREDDY.NS balance_sheet (annual, 2025-03-31) — Construction In Progress: 24838000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-03-31) — Construction In Progress: 24838000000.00
DRREDDY.NS income_statement (annual, 2025-03-31) — Cost Of Revenue: 135107000000.00
DRREDDY.NS income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 28500000000.00
DRREDDY.NS balance_sheet (annual, 2025-03-31) — Current Accrued Expenses: 25135000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 25135000000.00
DRREDDY.NS balance_sheet (annual, 2025-03-31) — Current Assets: 250112000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-03-31) — Current Assets: 250112000000.00
DRREDDY.NS balance_sheet (annual, 2025-03-31) — Current Capital Lease Obligation: 857000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 857000000.00
DRREDDY.NS balance_sheet (annual, 2025-03-31) — Current Debt: 38045000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-03-31) — Current Debt: 38045000000.00
DRREDDY.NS balance_sheet (annual, 2025-03-31) — Current Debt And Capital Lease Obligation: 38902000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 38902000000.00
DRREDDY.NS balance_sheet (annual, 2025-03-31) — Current Deferred Liabilities: 1983000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 1983000000.00
DRREDDY.NS balance_sheet (annual, 2025-03-31) — Current Deferred Revenue: 1983000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 1983000000.00
DRREDDY.NS balance_sheet (annual, 2025-03-31) — Current Liabilities: 130392000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 130392000000.00
DRREDDY.NS balance_sheet (annual, 2025-03-31) — Current Provisions: 6168000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-03-31) — Current Provisions: 6168000000.00
DRREDDY.NS cash_flow (annual, 2025-03-31) — Deferred Income Tax: 19539000000.00
DRREDDY.NS cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: 4182000000.00
DRREDDY.NS cash_flow (annual, 2025-03-31) — Deferred Tax: 19539000000.00
DRREDDY.NS cash_flow (quarterly, 2025-03-31) — Deferred Tax: 4182000000.00
DRREDDY.NS cash_flow (annual, 2025-03-31) — Depreciation: 10505000000.00
DRREDDY.NS cash_flow (quarterly, 2025-03-31) — Depreciation: 2635000000.00
DRREDDY.NS cash_flow (annual, 2025-03-31) — Depreciation Amortization Depletion: 17058000000.00
DRREDDY.NS cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 4554000000.00
DRREDDY.NS income_statement (annual, 2025-03-31) — Depreciation Amortization Depletion Income Statement: 17037000000.00
DRREDDY.NS income_statement (quarterly, 2025-03-31) — Depreciation Amortization Depletion Income Statement: 4547000000.00
DRREDDY.NS cash_flow (annual, 2025-03-31) — Depreciation And Amortization: 17058000000.00
DRREDDY.NS cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 4554000000.00
DRREDDY.NS income_statement (annual, 2025-03-31) — Depreciation And Amortization In Income Statement: 17037000000.00
DRREDDY.NS income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 4547000000.00
DRREDDY.NS income_statement (annual, 2025-03-31) — Diluted Average Shares: 834179134.00
DRREDDY.NS income_statement (annual, 2025-03-31) — Diluted EPS: 67.78
DRREDDY.NS income_statement (quarterly, 2025-03-31) — Diluted EPS: 19.10
DRREDDY.NS income_statement (annual, 2025-03-31) — Diluted NI Availto Com Stockholders: 56544000000.00
DRREDDY.NS income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 15933000000.00
DRREDDY.NS cash_flow (annual, 2025-03-31) — Dividends Received Cfi: 0.00
DRREDDY.NS cash_flow (quarterly, 2025-03-31) — Dividends Received Cfi: 0.00
DRREDDY.NS income_statement (annual, 2025-03-31) — EBIT: 79613000000.00
DRREDDY.NS income_statement (quarterly, 2025-03-31) — EBIT: 20708000000.00
DRREDDY.NS income_statement (annual, 2025-03-31) — EBITDA: 96671000000.00
DRREDDY.NS income_statement (quarterly, 2025-03-31) — EBITDA: 25262000000.00
DRREDDY.NS income_statement (annual, 2025-03-31) — Earnings From Equity Interest: 217000000.00
DRREDDY.NS income_statement (quarterly, 2025-03-31) — Earnings From Equity Interest: 55000000.00
DRREDDY.NS cash_flow (annual, 2025-03-31) — Earnings Losses From Equity Investments: -217000000.00
DRREDDY.NS cash_flow (quarterly, 2025-03-31) — Earnings Losses From Equity Investments: -55000000.00
DRREDDY.NS cash_flow (annual, 2025-03-31) — Effect Of Exchange Rate Changes: 224000000.00
DRREDDY.NS cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: 235000000.00
DRREDDY.NS cash_flow (annual, 2025-03-31) — End Cash Position: 14593000000.00
DRREDDY.NS cash_flow (quarterly, 2025-03-31) — End Cash Position: 14593000000.00
DRREDDY.NS balance_sheet (annual, 2025-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 1341000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 1341000000.00
DRREDDY.NS cash_flow (annual, 2025-03-31) — Financing Cash Flow: 18911000000.00
DRREDDY.NS cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -7370000000.00
DRREDDY.NS balance_sheet (annual, 2025-03-31) — Finished Goods: 28395000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-03-31) — Finished Goods: 28395000000.00
DRREDDY.NS cash_flow (annual, 2025-03-31) — Free Cash Flow: 12030000000.00
DRREDDY.NS cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 10750000000.00
DRREDDY.NS income_statement (annual, 2025-03-31) — Gain On Sale Of Ppe: 1522000000.00
DRREDDY.NS income_statement (quarterly, 2025-03-31) — Gain On Sale Of Ppe: 1067000000.00
DRREDDY.NS income_statement (annual, 2025-03-31) — Gain On Sale Of Security: 4876000000.00
DRREDDY.NS income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: 2444000000.00
DRREDDY.NS balance_sheet (annual, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: 3979000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: 3979000000.00
DRREDDY.NS income_statement (annual, 2025-03-31) — General And Administrative Expense: 55800000000.00
DRREDDY.NS income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 14006000000.00
DRREDDY.NS balance_sheet (annual, 2025-03-31) — Goodwill: 11810000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-03-31) — Goodwill: 11810000000.00
DRREDDY.NS balance_sheet (annual, 2025-03-31) — Goodwill And Other Intangible Assets: 108613000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 108613000000.00
DRREDDY.NS balance_sheet (annual, 2025-03-31) — Gross Accounts Receivable: 91898000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 91898000000.00
DRREDDY.NS balance_sheet (annual, 2025-03-31) — Gross PPE: 190380000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-03-31) — Gross PPE: 190380000000.00
DRREDDY.NS income_statement (annual, 2025-03-31) — Gross Profit: 190428000000.00
DRREDDY.NS income_statement (quarterly, 2025-03-31) — Gross Profit: 56560000000.00
DRREDDY.NS balance_sheet (annual, 2025-03-31) — Hedging Assets Current: 557000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-03-31) — Hedging Assets Current: 557000000.00
DRREDDY.NS income_statement (annual, 2025-03-31) — Impairment Of Capital Assets: 1693000000.00
DRREDDY.NS income_statement (quarterly, 2025-03-31) — Impairment Of Capital Assets: 768000000.00
DRREDDY.NS income_statement (annual, 2025-03-31) — Interest Expense: 2829000000.00
DRREDDY.NS income_statement (quarterly, 2025-03-31) — Interest Expense: 656000000.00
DRREDDY.NS income_statement (annual, 2025-03-31) — Interest Expense Non Operating: 2829000000.00
DRREDDY.NS income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 656000000.00
DRREDDY.NS income_statement (annual, 2025-03-31) — Interest Income: 2677000000.00
DRREDDY.NS income_statement (quarterly, 2025-03-31) — Interest Income: 564000000.00
DRREDDY.NS income_statement (annual, 2025-03-31) — Interest Income Non Operating: 2677000000.00
DRREDDY.NS income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 564000000.00
DRREDDY.NS cash_flow (annual, 2025-03-31) — Interest Paid Cff: -3483000000.00
DRREDDY.NS cash_flow (quarterly, 2025-03-31) — Interest Paid Cff: -846000000.00
DRREDDY.NS cash_flow (annual, 2025-03-31) — Interest Received Cfi: 3372000000.00
DRREDDY.NS cash_flow (quarterly, 2025-03-31) — Interest Received Cfi: 1065000000.00
DRREDDY.NS balance_sheet (annual, 2025-03-31) — Inventory: 71085000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-03-31) — Inventory: 71085000000.00
DRREDDY.NS balance_sheet (annual, 2025-03-31) — Invested Capital: 375233000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-03-31) — Invested Capital: 375233000000.00
DRREDDY.NS cash_flow (annual, 2025-03-31) — Investing Cash Flow: -58077000000.00
DRREDDY.NS cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -13300000000.00
DRREDDY.NS balance_sheet (annual, 2025-03-31) — Investmentin Financial Assets: 10391000000.00
DRREDDY.NS balance_sheet (quarterly, 2025-03-31) — Investmentin Financial Assets: 10391000000.00
DRREDDY.NS balance_sheet (annual, 2025-03-31) — Investments And Advances: 15202000000.00